Tag: active surveillance

I’ve said it before, and I’ll undoubtedly say it again: multiparametric MRI (mpMRI) can avoid unnecessary biopsies. In a previous blog, “A PROMIS is a Promise for Multiparametric MRI,” I cited the results of the PROMIS study in which 576 men initially had an mpMRI scan, then underwent 2 types of needle biopsy (ouch!) so keep reading

Multiparametric MRI (mpMRI) has sparked a revolution in prostate cancer (PCa) detection, diagnosis and image-guided treatments. Transrectal ultrasound (TRUS) does not even begin to compare with the anatomic definition and tissue characterization provided by high-resolution, 3D mpMRI scans. This breakthrough technology has been a godsend for patients in such areas as Avoiding unnecessary needle biopsies keep reading

On a daily basis—probably far more than we are aware—we choose one thing or another based on how we perceive the information we have. This car is better than that car, this tomato is perfect but that tomato looks damaged, clean-shaven looks good on me but a beard looks bad. As an ancient metaphor puts keep reading

I just read a terrific blog by a Chicago author, Howard Wolinsky, who has been on Active Surveillance for Wilensky 10 years. He has Gleason 3+3 prostate cancer—and is doing just fine! As he reflects on his own experience, he quotes from several experts in urologic surgery and clinical pathology. Spoiler alert: he articulates both keep reading

The average male human heart is slightly less than a half percent of total body weight, and it weighs about ten times more than the same man’s prostate gland. Most people would likely agree that the heart is at least ten times more important than the prostate. However, I suspect that the average man thinks keep reading

At first glance, the title question appears to have a self-evident answer. Everyone knows that a good workout program that includes at least 150 minutes of aerobic exercise is advantageous for the body’s cardiovascular system. This increases the chance of a long life in good health. And of course, we’re all aware that aerobic fitness keep reading

When the COVID pandemic began shutting us down in March 2020, life became surreal. The lockdown imposed dramatic changes in work/social life, and curtailed movement outside the home. Likewise, delivery of medical care suffered. Hospital staff were overwhelmed by the early waves of very ill and highly infectious patients, while well people who avoided routine keep reading

Who is the world’s leading prostate cancer expert? How does one even begin to answer that question? There are so many great minds dealing with prostate cancer from so many angles: biology, urology, radiology, oncology, pathology and more—it’s impossible to identify a single authority on the subject. However, when great minds work together, powerful consensus keep reading

In recent years, there’s been a huge groundswell of Active Surveillance (AS) for low-risk prostate cancer (PCa) patients. In fact, it’s considered the preferred PCa management strategy for men with lower-risk disease. There are two primary factors at play: 1) patient resistance to undergoing definitive whole gland treatments that can impair urinary and sexual function, keep reading

“Despite increasing adoption of active surveillance (AS) for low-risk prostate cancer, AS discontinuation rates are high, investigators report.” This quote, from a September 2021 Renal & Urology News report, referred to a study of over 16,000 Canadian prostate cancer (PCa) patients who had been diagnosed with low risk disease from 2008-2014. 51% of these patients keep reading